Corporate Tech Investors

Ligand Pharmaceuticals

Ligand Pharmaceuticals is a corporate VC investing group that invests in startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Ligand is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them to a lean corporate cost structure. Ligand's goal is to produce a bottom line that supports a sustainably profitable business. By diversifying our portfolio of assets across numerous technology types, therapeutic areas, drug targets and industry partners, we offer investors an opportunity to invest in the increasingly complicated and unpredictable pharmaceutical industry.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

6/1/2020

Transaction History

Our records indicate that Ligand Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

John Higgins

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Ligand Pharmaceuticals has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

LifeOmic | Lilly Asia Ventures

Share this article

About Our Corporate Tech Investor Database

The strategic investor data above is provided by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary